Compounds > 5-nitro-2-(3-phenylpropylamino)benzoic acid
Page last updated: 2024-11-01

5-nitro-2-(3-phenylpropylamino)benzoic acid and Coronary Artery Disease

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Coronary Artery Disease in 1 studies

5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hahn, M1
Stamer, UM1
Luedi, MM1
Book, M1
Rieder, HU1
Stüber, F1

Other Studies

1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Coronary Artery Disease

ArticleYear
ASA Status,
    Cells, 2022, 02-22, Volume: 11, Issue:5

    Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain;

2022